The Australian Government provides Pharmaceutical Benefits Scheme (PBS) subsidised access for somatropin to eligible paediatric and adult patients through the Growth Hormone Program established under section 100 of the National Health Act 1953.  

On 1 January 2020, changes were made to the PBS restrictions for growth hormone treatment in adults, which set out the eligibility requirements for PBS subsidy, to provide additional clarity and improved access to growth hormone treatment.

Prescribers are able to apply to Services Australia for the supply of Growth Hormone. Prescribing information, including Authority Application forms and other relevant documentation (as applicable) are available on the Services Australia website.